{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T20:22:19Z","timestamp":1789762939603,"version":"4.0.1"},"reference-count":40,"publisher":"European Respiratory Society (ERS)","issue":"1","license":[{"start":{"date-parts":[[2020,4,2]],"date-time":"2020-04-02T00:00:00Z","timestamp":1585785600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.ersjournals.com\/user-licence"}],"funder":[{"DOI":"10.13039\/501100003141","name":"Consejo Nacional de Ciencia y Tecnolog\u00eda","doi-asserted-by":"publisher","award":["(FOSISS project 2015-1-262511)"],"award-info":[{"award-number":["(FOSISS project 2015-1-262511)"]}],"id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["Eur Respir J"],"accepted":{"date-parts":[[2020,3,21]]},"published-print":{"date-parts":[[2020,7]]},"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>In animal models of pulmonary arterial hypertension (PAH), angiotensin-converting enzyme (ACE)2 and angiotensin (Ang)-(1\u20137) have been shown to have vasodilatory, antiproliferative, antifibrotic and antihypertrophic properties. However, the status and role of the ACE2-Ang(1\u20137) axis in human PAH is incompletely understood.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We studied 85 patients with a diagnosis of PAH of distinct aetiologies. 55 healthy blood donors paired for age and sex served as controls. Blood samples were obtained from the pulmonary artery in patients with PAH during right heart catheterisation. Peripheral blood was obtained for both groups. Ang(1\u20137) and -II were measured using zone capillary electrophoresis. Aldosterone, Ang(1\u20139), AngA and ACE2 were measured using ELISA, and ACE2 activity was determined enzymatically.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Of the 85 patients, 47 had idiopathic PAH, 25 had PAH associated with congenital heart disease and 13 had PAH associated with collagen vascular disease. Compared to controls, patients with PAH had a higher concentration of AngII (median 1.03, interquartile range 0.72\u20131.88\u2005pmol\u00b7mL<jats:sup>\u22121<\/jats:sup><jats:italic>versus<\/jats:italic>0.19, 0.10\u20130.37\u2005pmol\u00b7mL<jats:sup>\u22121<\/jats:sup>; p&lt;0.001) and of aldosterone (88.7, 58.7\u2013132 ng\u00b7dL<jats:sup>\u22121<\/jats:sup><jats:italic>versus<\/jats:italic>12.9, 9.55\u201319.9\u2005ng\u00b7dL<jats:sup>\u22121<\/jats:sup>; p&lt;0.001). Conversely, PAH patients had a lower concentration of Ang(1\u20137) than controls (0.69, 0.474\u20130.91\u2005pmol\u00b7mL<jats:sup>\u22121<\/jats:sup><jats:italic>versus<\/jats:italic>4.07, 2.82\u20136.73\u2005pmol\u00b7mL<jats:sup>\u22121<\/jats:sup>; p&lt;0.001), and a lower concentration of Ang(1\u20139) and AngA. Similarly, the ACE2 concentration was higher than in controls (8.7, 5.35\u201313.2\u2005ng\u00b7mL<jats:sup>\u22121<\/jats:sup><jats:italic>versus<\/jats:italic>4.53, 1.47\u201314.3 ng\u00b7mL<jats:sup>\u22121<\/jats:sup>; p=0.011), whereas the ACE2 activity was significantly reduced (1.88, 1.08\u20132.81 nmol\u00b7mL<jats:sup>\u22121<\/jats:sup><jats:italic>versus<\/jats:italic>5.97, 3.1\u201317.8 nmol\u00b7mL<jats:sup>\u22121<\/jats:sup>; p&lt;0.001). No significant differences were found among the three different aetiological forms of PAH.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The AngII\u2013ACE2\u2013Ang(1\u20137) axis appears to be altered in human PAH and we propose that this imbalance, in favour of AngII, plays a role in the pathogenesis of the severe PAH. Further mechanistic studies are warranted.<\/jats:p><\/jats:sec>","DOI":"10.1183\/13993003.02416-2019","type":"journal-article","created":{"date-parts":[[2020,4,2]],"date-time":"2020-04-02T12:25:13Z","timestamp":1585830313000},"page":"1902416","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":40,"title":["Angiotensin converting enzyme 2 and angiotensin (1\u20137) axis in pulmonary arterial hypertension"],"prefix":"10.1183","volume":"56","author":[{"given":"Julio","family":"Sandoval","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2999-1050","authenticated-orcid":false,"given":"Leonardo","family":"Del Valle-Mondrag\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felipe","family":"Masso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nayeli","family":"Zayas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom\u00e1s","family":"Pulido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Teijeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4370-9963","authenticated-orcid":false,"given":"Hector","family":"Gonzalez-Pacheco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rossana","family":"Olmedo-Ocampo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Sisniega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Araceli","family":"Paez-Arenas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo","family":"Pastelin-Hernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose","family":"Gomez-Arroyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert F.","family":"Voelkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"81","published-online":{"date-parts":[[2020,4,2]]},"reference":[{"key":"2024102101314550000_56.1.1902416.1","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01032-2015"},{"key":"2024102101314550000_56.1.1902416.2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-115-5-343"},{"key":"2024102101314550000_56.1.1902416.3","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.109.911818"},{"key":"2024102101314550000_56.1.1902416.4","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.1164\/rccm.201806-1160ST","article-title":"Assessment of right ventricular function in the research setting: knowledge gaps and pathways forward. An Official American Thoracic Society Research Statement","volume":"198","author":"Lahm","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"2024102101314550000_56.1.1902416.5","doi-asserted-by":"publisher","DOI":"10.1378\/chest.08-0492"},{"key":"2024102101314550000_56.1.1902416.6","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000140724.90898.D3"},{"key":"2024102101314550000_56.1.1902416.7","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200912-1856OC"},{"key":"2024102101314550000_56.1.1902416.8","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201203-0411OC"},{"key":"2024102101314550000_56.1.1902416.9","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201209-1663PP"},{"key":"2024102101314550000_56.1.1902416.10","doi-asserted-by":"publisher","DOI":"10.1007\/s11906-010-0122-6"},{"key":"2024102101314550000_56.1.1902416.11","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.113.301271"},{"key":"2024102101314550000_56.1.1902416.12","doi-asserted-by":"publisher","DOI":"10.1530\/JOE-12-0341"},{"key":"2024102101314550000_56.1.1902416.13","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200811-1678OC"},{"key":"2024102101314550000_56.1.1902416.14","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1164\/rccm.200912-1840OC","article-title":"The angiotensin converting enzyme 2\/angiogenesis-(1\u20137)\/Mas axis confers cardiopulmonary protection against lung fibrosis and pulmonary hypertension","volume":"182","author":"Shenoy","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"2024102101314550000_56.1.1902416.15","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02638-2017"},{"key":"2024102101314550000_56.1.1902416.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.talanta.2009.10.010"},{"key":"2024102101314550000_56.1.1902416.17","doi-asserted-by":"publisher","DOI":"10.1186\/ar3012"},{"key":"2024102101314550000_56.1.1902416.18","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2004.029082"},{"key":"2024102101314550000_56.1.1902416.19","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1164\/rccm.201608-1630PP","article-title":"The roles of immunity in the prevention and evolution of pulmonary arterial hypertension","volume":"195","author":"Nicolls","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"2024102101314550000_56.1.1902416.20","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2009.01.016"},{"key":"2024102101314550000_56.1.1902416.21","doi-asserted-by":"publisher","DOI":"10.1002\/1096-9896(2000)9999:9999<::AID-PATH715>3.0.CO;2-Q"},{"key":"2024102101314550000_56.1.1902416.22","doi-asserted-by":"publisher","DOI":"10.1183\/09059180.00007109"},{"key":"2024102101314550000_56.1.1902416.23","first-page":"1381","article-title":"Angiotensin-converting enzyme 2 activation protects against pulmonary arterial hypertension through improving early endothelial function and mediating cytokines levels","volume":"125","author":"Li","year":"2012","journal-title":"Chin Med J"},{"key":"2024102101314550000_56.1.1902416.24","doi-asserted-by":"publisher","DOI":"10.1016\/j.peptides.2012.01.020"},{"key":"2024102101314550000_56.1.1902416.25","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.114.03871"},{"key":"2024102101314550000_56.1.1902416.26","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.12688\/f1000research.14984.1","article-title":"Recent advances in pulmonary arterial hypertension","volume":"7","author":"Wilkins","year":"2018","journal-title":"F1000Res"},{"key":"2024102101314550000_56.1.1902416.27","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.coph.2017.12.002","article-title":"Targeting the renin\u2013angiotensin system as novel therapeutic strategy for pulmonary diseases","volume":"40","author":"Tan","year":"2018","journal-title":"Curr Opin Pharmacol"},{"key":"2024102101314550000_56.1.1902416.28","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/j.ijcard.2014.08.021","article-title":"Decreased levels of serum angiotensin-(1-7) in patients with pulmonary arterial hypertension due to congenital heart disease","volume":"176","author":"Dai","year":"2014","journal-title":"Int J Cardiol"},{"key":"2024102101314550000_56.1.1902416.29","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.111.177485"},{"key":"2024102101314550000_56.1.1902416.30","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0000000000000094"},{"key":"2024102101314550000_56.1.1902416.31","doi-asserted-by":"crossref","first-page":"447","DOI":"10.4196\/kjpp.2018.22.4.447","article-title":"Angiotensin-(1-9) ameliorates pulmonary arterial hypertension via angiotensin type II receptor","volume":"22","author":"Cha","year":"2018","journal-title":"Korean J Physiol Pharmacol"},{"key":"2024102101314550000_56.1.1902416.32","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2016.07.025"},{"key":"2024102101314550000_56.1.1902416.33","doi-asserted-by":"publisher","DOI":"10.1086\/675984"},{"key":"2024102101314550000_56.1.1902416.34","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.107.742510"},{"key":"2024102101314550000_56.1.1902416.35","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.healun.2015.10.019","article-title":"Elevated pulmonary arterial and systemic plasma aldosterone levels associate with impaired cardiac reserve capacity during exercise in left ventricular systolic heart failure patients: a pilot study","volume":"35","author":"Maron","year":"2016","journal-title":"J Heart Lung Transplant"},{"key":"2024102101314550000_56.1.1902416.36","doi-asserted-by":"crossref","unstructured":"Wang Y , Zhong B , Wu Q , et al. Aldosterone contributed to pulmonary arterial hypertension development via stimulating aquaporin expression and pulmonary arterial smooth muscle cells proliferation. Pharmacology 2020; 1\u201311. 10.1159\/000504228.","DOI":"10.1159\/000504228"},{"key":"2024102101314550000_56.1.1902416.37","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00046612"},{"key":"2024102101314550000_56.1.1902416.38","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00217.2020"},{"key":"2024102101314550000_56.1.1902416.39","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/s13046-019-1156-5","article-title":"ACE2 inhibits breast cancer angiogenesis via suppressing the VEGFa\/VEGFR2\/ERK pathway","volume":"38","author":"Zhang","year":"2019","journal-title":"J Exp Clin Cancer Res"},{"key":"2024102101314550000_56.1.1902416.40","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00848-2018"}],"updated-by":[{"DOI":"10.1183\/13993003.52416-2019","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T00:00:00Z","timestamp":1749081600000}}],"container-title":["European Respiratory Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/13993003.02416-2019","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T07:31:30Z","timestamp":1740382290000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/13993003.02416-2019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,2]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,7,23]]},"published-print":{"date-parts":[[2020,7]]}},"alternative-id":["10.1183\/13993003.02416-2019"],"URL":"https:\/\/doi.org\/10.1183\/13993003.02416-2019","relation":{},"ISSN":["0903-1936","1399-3003"],"issn-type":[{"value":"0903-1936","type":"print"},{"value":"1399-3003","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,2]]}}}